467
edits
Heart Failure: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 696: | Line 696: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Furosemide | ||
|valign="bottom"| | |valign="bottom"| | ||
Renal failure | Renal failure | ||
| Line 704: | Line 704: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Bumetanide | ||
|valign="bottom"| | |valign="bottom"| | ||
Renal failure | Renal failure | ||
| Line 714: | Line 714: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Captopril | ||
| | | | ||
|Start:::6.25mg | |Start:::6.25mg | ||
| Line 725: | Line 725: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Lisinopril | ||
| | | | ||
|Start:::2.5-5mg | |Start:::2.5-5mg | ||
| Line 736: | Line 736: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Enalapril/quinalapril | ||
| | | | ||
|Start:::2.5-5mg | |Start:::2.5-5mg | ||
| Line 749: | Line 749: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Metoprolol zoc (succinate) | ||
|valign="top"|EF >30-45% and NYHA II-III | |valign="top"|EF >30-45% and NYHA II-III | ||
|Start:::25mg | |Start:::25mg | ||
| Line 770: | Line 770: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Bisoprolol | ||
|valign="top"|EF >30-45% and NYHA II-III | |valign="top"|EF >30-45% and NYHA II-III | ||
|Start:::2.5mg | |Start:::2.5mg | ||
| Line 791: | Line 791: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Carvedilol | ||
|valign="top"|EF >30-45% and NYHA II-III | |valign="top"|EF >30-45% and NYHA II-III | ||
|Start:::6.25mg | |Start:::6.25mg | ||
| Line 812: | Line 812: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Nebivolol | ||
|valign="top"|EF >30-45% and NYHA II-III | |valign="top"|EF >30-45% and NYHA II-III | ||
|Start:::1.25mg | |Start:::1.25mg | ||
| Line 835: | Line 835: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Spironolactone/eplerenone | ||
| | | | ||
|Start:::25mg s.i.d. | |Start:::25mg s.i.d. | ||
| Line 852: | Line 852: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Digoxin | ||
| | | | ||
|Start:::0.5mg, 0.25mg and 0,25 mg, each with 6 hours in between | |Start:::0.5mg, 0.25mg and 0,25 mg, each with 6 hours in between | ||
| Line 863: | Line 863: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Candesartan | ||
| | | | ||
|Start:::4mg | |Start:::4mg | ||
| Line 872: | Line 872: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Valsartan | ||
| | | | ||
|Start:::80mg | |Start:::80mg | ||
| Line 883: | Line 883: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *Hydralazine | ||
| | | | ||
|Start:::25mg three times daily. | |Start:::25mg three times daily. | ||
| Line 892: | Line 892: | ||
|- | |- | ||
|valign="top"| | |valign="top"| | ||
* | *ISDN | ||
| | | | ||
|Start:::20mg twice daily | |Start:::20mg twice daily | ||